The Cryo-Save difference – providing families who believe in the future of regenerative medicine and tissue engineering access to current and future stem cell therapies.
Cryo-Save South Africa is part of the Cryo-Save Group, Europe’s largest private cord blood and tissue stem cell bank. Through its six international laboratories in Geneva, Belgium, Germany, Dubai, India and South Africa, Cryo-Save globally stores more than 310 000 samples and is represented in over 30 countries on six continents.
Locally, it is also part of the private equity stable of Ecsponent Limited, a JSE-listed financial services group. Cryo-Save forms part of the specialised Ecsponent Biotech that invests in products and services that promote the adoption of personalised and regenerative medicine among South Africans to improve their quality of life.
As part of your birthing plan, contact us as early in your pregnancy as possible.
5TH MOST INFLUENTIAL CORD BANK IN THE WORLD AND EUROPEAN MARKET LEADER
Cryo-Save is ranked the 5th most influential cord bank in the world by BioInformant, the global leader in stem cell market research, and remains the undisputed European leader in the stem cells industry after 17 years of technological excellence.
Established in 2000, Cryo-Save is the most experienced, reliable and technologically advanced family Stem Cell Bank in Europe with six fully-owned storage facilities throughout the world. We are collecting samples from more than 30 countries and currently storing more than 330.000 samples of stem cells sourced from perinatal tissues.
Cryo-Save is led by a team of medical and scientific professionals, ensuring the highest quality of processes from collection through to storage. The dedicated medical professional presence in all countries we operate provides our clients and partners with direct expert communication and support.
GENEVA FLAGSHIP LABORATORY
Values of excellence, quality, performance and sustainability
The flagship laboratory is located in Geneva with a further five facilities in Belgium, the Netherlands, Portugal, South Africa and UAE, each carrying the Swiss values of high quality, high security and a long-term view.
Cryo-Save is the largest European family stem cell bank fully authorised for autologous and allogeneic transplants by a State Agency for therapeutic products and is fully accredited as a licensed Organ and Tissue Establishment.
Laboratory facilities within the Cryo-Save network are locally registered and acknowledged to support stem cell storage services across the 25 countries where Cryo-Save is currently active. In addition to the local licensing requirements, met by the six processing and storage facilities, Cryo-Save holds several accreditations and certifications – ISO 9001, EUGMP/PICs and AABB.
Cryo-Save laboratories have over 15 years’ experience in processing, cryopreservation and quality development. We strive to continue implementing process improvements across all facilities to ensure that the Cryo-Save name stands synonymous with quality.
PREPARING FOR THE FUTURE
Processing capacity was scaled up at the Geneva site during 2015 in preparation for consolidating most of the European laboratory activities at this single, state-of-the-art, high-tech laboratory.
The portfolio of quality accreditations was expanded and will continue to grow in the coming year as we anticipate future quality improvements demanded by the medical industry. Geneva has replaced Belgium as the flagship facility for Cryo-Save offering the latest in technological advancement as well as cost efficiencies inherent in such a large scale, automated, high-throughput facility.
TRANSLATIONAL RESEARCH AND REGENERATIVE MEDICINE
The Cell Factory produces highest quality stem cells and exosomes according to GLP/GMP guidelines, using proprietary technology for expansion of mesenchymal stem cells (MSC).
- Building new procedures and services from R&D within Esperite group
- Bringing most advanced regenerative medicine into a clinical setting
- Constant optimisation of stem cell processes ensuring maximum yields, purity and low production costs
- In-house scientific and medical expertise ensuring optimal development
- Five international patents
- Clinical trials on disorders affecting children from birth
- Leading an international consortium of experts